K961053 is an FDA 510(k) clearance for the SERAQUEST RUBELLA IGG. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Rubella (Class II - Special Controls, product code LFX).
Submitted by Quest Intl., Inc. (North Miami, US). The FDA issued a Cleared decision on September 4, 1996, 170 days after receiving the submission on March 18, 1996.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3510.
| 510(k) Number | K961053 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | March 18, 1996 |
| Decision Date | September 04, 1996 |
| Days to Decision | 170 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LFX — Enzyme Linked Immunoabsorbent Assay, Rubella |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.3510 |